Murcko scaffold
Ring system with 4 rings and 38 atoms
42 chemicals on CompoundList share this ring system.
- Rings
- 4
- Scaffold atoms
- 38
- Chemicals
- 42
- With full pages
- 11
Scaffold SMILES
O=C1CCCC(OC2CCC(OC3CCCCO3)CO2)CCCC(OC2CCCCO2)C=CC=CCCO1
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 42 of 42 chemicals
Spiramycin adipate
C49H84N2O18
Spiramycin I
CAS 24916-50-5C43H74N2O14
Foromacidin C, spiramycin III
CAS 889888-56-6C46H78N2O15
3'',4''-Diacetylspiramycin II
CAS 110101-92-3C49H80N2O17
Diacetylspiramycin III
CAS 99664-83-2C50H82N2O17
3'',4''-Diacetylspiramycin III
CAS 110159-29-0C50H82N2O17
Spiramycin embonate
CAS 67724-08-7C66H90N2O20
Spiramycin adipate
CAS 68880-55-7C49H84N2O18
Chimeramycin A
CAS 87084-47-7C47H80N2O14
Chimeramycin B
CAS 87092-83-9C45H78N2O13
Spiramycin II
CAS 24916-51-6C45H76N2O15
Spiramycin III
CAS 24916-52-7C46H78N2O15
Leucomycin V, 9-O-(5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-, (9(5S,6R))-, (1,2-ethanediylbis(imino-4,1-phenylene))bis(arsonate) (1:1) (salt)
CAS 93841-79-3C57H92As2N4O20
![4-[(3-Carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid, 2-[(4R,5S,6S,7R,9R,10R,16R)-6-[(2S,3R,4S,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde chemical structure, C66H90N2O20](/s/BJKLPSFSLQTCGC-KHKRUTKBSA-N.svg)
4-[(3-Carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid, 2-[(4R,5S,6S,7R,9R,10R,16R)-6-[(2S,3R,4S,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde
C66H90N2O20
Leucomycin V, 9-O-(5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-, (9(5S,6R))-, 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylate) (1:1) (salt)
CAS 97862-04-9C66H90N2O20
RefChem:153096
CAS 97862-05-0C68H92N2O21
Leucomycin V, 9-O-(5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-, 3-propanoate, (9(5S,6R))-, 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylate) (1:1) (salt)
CAS 97862-06-1C69H94N2O21
Spiramycin I adipate
CAS 23293-98-3C49H84N2O18
Spiramycin I-d3
CAS 1355452-20-8C43H74N2O14
Spiramycin adipate
C49H84N2O18
Orb321183
C66H90N2O20
4''-Acetylspiramycin I
CAS 130482-07-4C45H76N2O15
Spiramycin II acetate
CAS 87111-42-0C47H78N2O16
4''-Acetylspiramycin III
CAS 112501-15-2C48H80N2O16
- 6 suppliersEpoetin alfa11096-26-7C42H73NO16
- Isovalerylspiramycin I267662-22-6C48H82N2O15
- Orb3179723848080-53-5C50H84N2O16
- Isovalerylspiramycin III212125-76-3C51H86N2O16
- (4R,5S,6S,7S,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-Dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-7-ethyl-4-hydroxy-5-methoxy-9,16-dimethyl-1-oxacyclohexadeca-11,13-dien-2-oneC43H76N2O13
- 4-[(3-Carboxy-2-hydroxy-naphthalen-1-yl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid, 2-[(2R,4E,6E,8R,9R,11R,12S,13S,14R)-12-[(2S,3R,4S,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-oxan-2-yl]oxy-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-8-C66H90N2O20
- 4-[(3-Carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid, 2-[(4R,5S,6S,7R,9R,10R,11Z,13Z,16R)-6-[(2S,3R,4S,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehydeC66H90N2O20
- Spiramycin, hexanedioate11034-40-5C49H84N2O18
- Spiramycin S87718-67-0C42H73NO16
- Spiramycin EP impurity B249930-66-3C43H76N2O14
- Spiramycin adipateC49H84N2O18
- [9(2R,5S,6R)]-9-O-[5-(Dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]-3-O-methyl-17-methylene-leucomycin V177584-13-3C44H74N2O14
- 2-[(4R,5S,6S,7R,9R,10R,11Z,13Z,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-Dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-10-[(5S,6R)-6-methyl-5-[methyl(trideuteriomethyl)amino]oxan-2-yl]oxy-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehydeC43H74N2O14
- 4-[(3-Carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid, 2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4S,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehydeC66H90N2O20
- Spiramycin EP impurity BC43H76N2O14
- 18-Deoxo-9-O-[(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]-3-Omethylleucomycin V177584-14-4C43H76N2O13
- Spiramycin EP impurity EC43H76N2O13
- Spiramycin EP impurity D87708-39-2C42H71NO16